203 related articles for article (PubMed ID: 9627860)
1. Ophthalmic drug development: procedural considerations.
Novack GD
J Glaucoma; 1998 Jun; 7(3):202-9. PubMed ID: 9627860
[No Abstract] [Full Text] [Related]
2. Good clinical practice--a practical experience.
Ogunsola FT
Nig Q J Hosp Med; 2008; 18(2):123-4. PubMed ID: 19068567
[No Abstract] [Full Text] [Related]
3. Good clinical practice in clinical drug trials--what you need to know.
Soyebi K; Abosede ; Coker HA; Osuntoki ; Oyibos W; Keri H; Ogunsola S
Nig Q J Hosp Med; 2008; 18(2):104-12. PubMed ID: 19068563
[No Abstract] [Full Text] [Related]
4. Productivity counts--but the definition is key.
Mervis J
Science; 2005 Jul; 309(5735):726. PubMed ID: 16051784
[No Abstract] [Full Text] [Related]
5. Food and Drug Administration approval process for ophthalmic drugs in the US.
Lloyd R; Harris J; Wadhwa S; Chambers W
Curr Opin Ophthalmol; 2008 May; 19(3):190-4. PubMed ID: 18408492
[TBL] [Abstract][Full Text] [Related]
6. Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jul; 73(136):40453-63. PubMed ID: 18850678
[TBL] [Abstract][Full Text] [Related]
7. [From molecule to medicine--drug development].
Bruhn C
Dtsch Med Wochenschr; 2010 Feb; 135(6):p5. PubMed ID: 20151355
[No Abstract] [Full Text] [Related]
8. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
9. Leveraging exploratory investigational new drug studies to accelerate drug development.
Jacobson-Kram D; Mills G
Clin Cancer Res; 2008 Jun; 14(12):3670-4. PubMed ID: 18559581
[TBL] [Abstract][Full Text] [Related]
10. Pediatric drug development in anesthesiology: an FDA perspective.
Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
[No Abstract] [Full Text] [Related]
11. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
[TBL] [Abstract][Full Text] [Related]
12. Designing a molecular delivery system within a preclinical timeframe.
Henck JO; Byrn SR
Drug Discov Today; 2007 Mar; 12(5-6):189-99. PubMed ID: 17331883
[TBL] [Abstract][Full Text] [Related]
13. Preclinical predictors of clinical safety: opportunities for improvement.
Sistare FD; DeGeorge JJ
Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
[TBL] [Abstract][Full Text] [Related]
14. Charging for investigational drugs under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
[TBL] [Abstract][Full Text] [Related]
15. Implications of pharmacogenomics for drug development.
Kirk RJ; Hung JL; Horner SR; Perez JT
Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
[TBL] [Abstract][Full Text] [Related]
16. Financing new drug development in ophthalmology.
Novack GD
J Glaucoma; 2000 Apr; 9(2):195-9. PubMed ID: 10782633
[TBL] [Abstract][Full Text] [Related]
17. The Early Preclinical Development Program for Locally Administered Investigational Medicinal Products in Ophthalmology: Preclinical Data Required for Starting a First-in-Human Clinical Trial in Europe-Basic Considerations and 2 Case Studies.
Toggenburger A; Trönnberg R; Galland A; Mathis GA
Ther Innov Regul Sci; 2018 May; 52(3):321-328. PubMed ID: 29714531
[TBL] [Abstract][Full Text] [Related]
18. The development of new drugs for ophthalmology.
Novack GD
Am J Ophthalmol; 1992 Sep; 114(3):357-64. PubMed ID: 1524128
[No Abstract] [Full Text] [Related]
19. Trials and tribulations: a primer on successfully navigating the waters of the Food and Drug Administration.
Feinsod M; Chambers WA
Ophthalmology; 2004 Oct; 111(10):1801-6. PubMed ID: 15465539
[TBL] [Abstract][Full Text] [Related]
20. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
